Quest Diagnostics - Press Releases

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996

Quest Diagnostics to Speak at Merrill Lynch Health Services Investor Conference

12/02/3

Quest Diagnostics Announces Succession Plan; Surya N. Mohapatra, Ph.D., to Succeed Kenneth W. Freeman as CEO in 2004

11/10/3

Quest Diagnostics to Speak at the CIBC World Markets 14th Annual Health Care Conference

11/07/3

Drug Use Climbed in the U.S. Workforce in the First Half of 2003, Driven by Continued Growth in Use of Amphetamines, According to Quest Diagnostics' Drug Testing Index

11/05/3

Quest Diagnostics Earnings Per Share Increased 29% in Third Quarter 2003

10/21/3

Quest Diagnostics Initiates Quarterly Cash Dividend And Increases Share Repurchase Authorization by $300 Million

10/21/3

Quest Diagnostics Appoints Mervyn A. Sahud, M.D., to Lead Coagulation Laboratory Program

10/16/3

Delbert Fisher, M.D., Vice President for Science and Innovation At Quest Diagnostics, Is Honored by The National Institute Of Child Health and Human Development (NICHD)

10/08/3

Quest Diagnostics Appoints Renowned Cancer Scientist, Maher Albitar, M.D., Medical Director for Hematopathology

09/30/3

Quest Diagnostics to Speak at UBS Global Life Sciences Conference

09/19/3

Quest Diagnostics to Speak at The Banc of America Securities 33rd Annual Investment Conference

09/15/3

Quest Diagnostics to Speak at the Thomas Weisel Partners Healthcare Tailwinds 2003 Conference

09/03/3

Quest Diagnostics Offers InSure(TM) Colorectal Cancer Screening Test To Help Physicians Identify Cancer at an Early Stage

08/07/3

Quest Diagnostics Sponsors Distribution of the National Comprehensive Cancer Network's CD-ROM on Cancer Testing Guidelines for Non-Cancer Specialists

08/04/3

Quest Diagnostics Expands Heart Disease Test Offerings With Lp-PLA2 Test For Cardiovascular Risk Assessment

07/24/3

Quest Diagnostics Earnings Per Share Increased 29% In Second Quarter 2003

07/22/3

Quest Diagnostics to Speak at the 2003 Wachovia Securities Nantucket Equity Conference

06/25/3

Quest Diagnostics to Speak at the Thomas Weisel Partners Growth Forum 5.0

06/17/3

Quest Diagnostics to Speak at the Goldman Sachs Twenty-Fourth Annual Global Healthcare Conference

06/09/3

Quest Diagnostics and Stop & Shop Partner to Offer QuesTest(TM) Consumer Health Testing Services in Connecticut

06/05/3

Amphetamine Use Increases In the General U.S. Workforce, According to Quest Diagnostics' 2002 Drug Testing Index

05/27/3

Quest Diagnostics and Enterix Enter Into an Agreement to Offer InSure(TM), A Patient-Friendly Immunochemical Test for Colorectal Cancer Screening

05/19/3

Quest Diagnostics Announces Share Repurchase Plan

05/13/3

Quest Diagnostics Presentation at Deutsche Bank Securities Healthcare Conference Available on Internet

05/06/3

Quest Diagnostics Reports Strong Earnings Per Share Growth In First Quarter 2003

04/22/3

Quest Diagnostics and Thermo Electron Launch First Commercial Gene-based Medical Test Using a Biochip

04/17/3

Quest Diagnostics to Speak at Wachovia Securities Cancer Diagnostics Conference

04/09/3

Quest Diagnostics Appoints Robert E. Peters Vice President, Sales and Marketing

03/25/3

Quest Diagnostics to Speak at the Banc of America Securities Healthcare Conference

03/24/3

Quest Diagnostics to Speak At the SG Cowen 23rd Annual Health Care Conference

03/17/3

Quest Diagnostics Successfully Completes Unilab Debt Tender Offer

03/07/3

Quest Diagnostics to Speak at Wachovia Securities Ninth Annual Convertible Securities Conference

03/06/3

Quest Diagnostics Sets Purchase Price in Tender Offer and Consent Solicitation for Unilab 12 3/4% Senior Subordinated Notes Due 2009

03/05/3

Quest Diagnostics Announces Final Results of Unilab Exchange Offer

03/04/3

Quest Diagnostics Announces Preliminary Results of Unilab Exchange Offer

03/03/3

Quest Diagnostics Announces Receipt of Requisite Consents in Cash Tender For Unilab 12 3/4% Senior Subordinated Notes Due 2009

02/27/3

Quest Diagnostics Acquires Unilab

02/26/3

Quest Diagnostics Updates 2003 Guidance

02/25/3

Quest Diagnostics Receives FTC Clearance to Proceed With Acquisition of Unilab

02/21/3

Quest Diagnostics Extends Consent Date for Cash Tender Offer to Purchase All Outstanding Unilab 12 3/4% Senior Subordinated Notes

02/21/3

Quest Diagnostics Extends Exchange Offer for Shares of Unilab

02/19/3

James F. Flaherty III Elected to Quest Diagnostics Board of Directors

02/13/3

Quest Diagnostics Extends Exchange Offer for Shares of Unilab

02/11/3

Quest Diagnostics Launches eMaxx(R) Web Portal, Giving Physicians Access to Lab Tests and Other Clinical Information On-Line

02/10/3

Top Ranking by KLAS Enterprises for Electronic Patient Record Solution Awarded to Quest Diagnostics' MedPlus(TM) Subsidiary

02/06/3

Quest Diagnostics Incorporated Commences Cash Tender Offer for Unilab Corporation 12-3/4% Senior Subordinated Notes Due 2009

02/06/3

Quest Diagnostics to Sell Certain Assets in Northern California to LabCorp - Quest Diagnostics Extends Exchange Offer for Shares of Unilab -

02/04/3

Quest Diagnostics to Speak at UBS Warburg Global Healthcare Services Conference

01/31/3

Quest Diagnostics to Speak At U.S. Bancorp Piper Jaffray Health Care Conference

01/27/3

Quest Diagnostics Discloses Guidance on Webcasted Investor Call

01/24/3

Quest Diagnostics Announces Increased Revenues and Earnings For Fourth Quarter and Full Year 2002

01/23/3

Quest Diagnostics Extends Exchange Offer for Shares of Unilab

01/21/3

Quest Diagnostics and Unilab to Distribute Materials Regarding Changes to Exchange Offer

01/17/3

Quest Diagnostics Extends Exchange Offer for Shares of Unilab

01/07/3

PAREXEL and Quest Diagnostics Establish Collaboration to Co-Market Clinical Trials Services

01/07/3

Quest Diagnostics to Speak at the 21st Annual JPMorgan H&Q Healthcare Conference

01/06/3

Quest Diagnostics and Unilab Amend Merger Agreement

01/06/3